Denali Therapeutics Inc.
Kinase inhibitors and uses thereof

Last updated:

Abstract:

The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

Status:
Grant
Type:

Utility

Filling date:

14 Nov 2019

Issue date:

21 Dec 2021